Skip to content

Efficacy of Strengthening Spleen Smoothing Liver Granules on Breast Cancer-related Fatigue: A Multicenter, Single-arm study

Clinical Study of Traditional Chinese Medicine on Breast Cancer-related Fatigue

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOB-15007079
Enrollment
Unknown
Registered
2015-09-15
Start date
2015-07-09
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer-related Fatigue

Interventions

Treatment Group:Strengthening Spleen Smoothing Liver Granules

Sponsors

Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as breast cancer by histopathology or cytology; 2. More than 1 month before the end of chemotherapy or radiotherapy; 3. ECOG score: 0-2 points; 4. In accordance with the standards of spleen deficiency liver depression syndrome; 5. The excepted survival time >=6 months; 6. No chemotherapy or radiotherapy during the study period; 7. Piper score>=4 pionts; 8. Volunteers, signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Serious disease such as cardiovascular, liver, kidney, immune hematopoietic tem disorder; 2. Children,or pregnant women; 3. Under therapy of using erythropoietin, iron, folic acid, vitamin B12, sex hormones; 4. Under therapy of steroid for cancer-related fatigue; 5. Diagnosed as depression, anxiety, mental disease or cognitive disorder; 6. Allergic to chinese herbal compound.

Design outcomes

Primary

MeasureTime frame
Chinese Rating Scale;Piper Score;ECOG Score;

Secondary

MeasureTime frame
PSQI Score;HAD Score;BFI Score;

Countries

China

Contacts

Public ContactWang Xiaomin
wangxiaomin_bhtcm@126.com+86 010-52176673

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026